This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The Board of Regents of the University of Nebraska, Beth Israel Deaconess Medical Center, Inc.. Active years: 2014-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014-2025
Title: The Innovations of Hasan Huseyin Otu
Introduction
Hasan Huseyin Otu is an accomplished inventor based in Lincoln, NE. He has made significant contributions to the field of medical diagnostics and treatment, particularly concerning liver diseases. His innovative work focuses on non-alcoholic steatohepatitis (NASH) and advanced liver fibrosis.
Latest Patents
Hasan Huseyin Otu holds a patent for "Markers for the diagnosis and treatment of non-alcoholic steatohepatitis (NASH) and advanced liver fibrosis." This patent includes methods for diagnosing NASH and differentiating it from simple steatosis. The invention also provides treatment methods for NASH by administering biomarkers or agents that modulate these biomarkers. Additionally, it offers compositions in the form of kits and panels of reagents for detecting the biomarkers associated with NASH.
Career Highlights
Throughout his career, Hasan has worked with notable institutions, including Beth Israel Deaconess Medical Center and the University of Nebraska. His experience in these organizations has allowed him to develop and refine his innovative approaches to diagnosing and treating liver conditions.
Collaborations
Hasan has collaborated with esteemed colleagues such as Towia Aron Libermann and Michelle Lai. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Hasan Huseyin Otu's contributions to medical science, particularly in the diagnosis and treatment of liver diseases, highlight his role as a significant inventor in the field. His innovative approaches and collaborations continue to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile